Read Simon
SEC insider (Form 3/4/5 filer). CIK 0001688199. Director at Dianthus Therapeutics, Inc. /DE/ (DNTH). 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 19, 2026. Located in NEW YORK, NY.
Companies Read Simon has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Director
Read Simon
CIK: 0001688199
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dianthus Therapeutics, Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 19, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect2.8K shares at avg. $18.36$51K - Aug 19, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect2.8K shares at avg. $117.55$327K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect737 shares at avg. $108.17$80K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect831 shares at avg. $108.95$91K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect272 shares at avg. $109.96$30K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect470 shares at avg. $111.05$52K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect397 shares at avg. $111.77$44K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect2.8K shares at avg. $18.36$51K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect70 shares at avg. $107.11$7K - May 21, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
AwardDirectStock Option (Right to Buy)
6.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 19, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 2,778 | $18.36 | $51,004 | Direct |
| Aug 19, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 2,778 | $117.55 | $326,554 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 737 | $108.17 | $79,721 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 831 | $108.95 | $90,537 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 272 | $109.96 | $29,909 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 470 | $111.05 | $52,194 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 397 | $111.77 | $44,373 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 2,777 | $18.36 | $50,986 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 70 | $107.11 | $7,498 | Direct |
| May 21, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Award Stock Option (Right to Buy) | 6,090 | - | - | Direct |
1-10 of 11 transactions